GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

MedPlus Health Services MEDPLUS.NS · INR

Consumer Staples · NSE · 🇮🇳 India

Compare

596.00

-1.42%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About MedPlus Health Services

Its shares trade on NSE under the ticker MEDPLUS.NS. It has been listed since 23 December 2021. In the fiscal year to 31 March 2026, it reported revenue of ₹68.92bn and net income of ₹2.20bn. At that date it held total assets of ₹39.33bn and shareholders' equity of ₹19.75bn.

MedPlus Health Services Ltd. engages in the operation of pharmacies. The company is headquartered in Hyderabad, Telangana. The company went IPO on 2021-12-23. The firm is primarily engaged in retail trading of medicines and general items, wholesale cash and carry and pathological laboratory testing services, wholesale trading and manufacturing of pharmaceutical products, fast-moving consumer goods and beauty products. The company operates through two segments: Retail and Diagnostics. The Retail segment is engaged in retail trading of medicines and general items. The Diagnostics segment is engaged in the diagnostic services. The firm operates approximately 3,882 stores in 552 cities distributed across Tamil Nadu, Andhra Pradesh, Telangana, Karnataka, Odisha, West Bengal, and Maharashtra. Its omni-channel platform enables the Company to service its customers through its stores, as well as its online channels. Its subsidiaries include Optival Health Solutions Private Limited, MHS Pharmaceuticals Private Limited, Kalyani Meditimes Private Limited, and others.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Consumer Staples
Industry
Consumer Staples Distribution & Retail
Listed since
23 Dec 2021
Employees
21,000

Leadership

Pay as last reported

  • Mr. Gangadi ReddyExecutive Chairman of the Board, Chief Executive Officer, Managing Director, since 2006₹4.4m
  • Mr. Sujit MahatoChief Financial Officer₹20.5m
  • Dr. Cherukupalli ReddyChief Operating Officer, Whole-time Director, since 2007₹11.9m
  • Mr. Subrahmanyam TatapudiChief Technology Officer
  • Mr. Manoj SrivastavaHead - Corporate Secretarial, Compliance Officer, Company Secretary₹6.6m
  • Mr. Kandasamy VairaperumalHead of Supply Chain
  • Mr. Madhavan GanesanNon-Executive Independent Director₹1.4m
  • Mr. Thyagarajan MuralidharanNon-Executive Independent Director₹200,000
  • Mr. Murali SivaramanNon-Executive Independent Director₹1.3m
  • Ms. Aparna SurabhiNon-Executive Independent Director₹950,000

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • MedPlus operates 3,882 stores across 552 cities in India.
  • MedPlus has 21,000 employees supporting its retail and diagnostic segments.
  • MedPlus offers omni-channel services through stores and online platforms.

Weaknesses

  • MedPlus operates primarily in India with limited international presence.
  • MedPlus has no mention of manufacturing capabilities in its business description.
  • MedPlus does not specify any unique product differentiation in its retail offerings.

Opportunities

  • MedPlus can expand its diagnostic services in underserved regions of India.
  • MedPlus can leverage its omni-channel platform for further digital growth.
  • MedPlus can increase its product range in fast-moving consumer goods and beauty products.

Threats

  • MedPlus faces competition from other pharmacy chains in India.
  • MedPlus must comply with evolving healthcare regulations in India.
  • MedPlus is vulnerable to economic downturns affecting consumer spending on non-essential items.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.